I. Introduction to Melanoma and Early Detection
Melanoma, a malignant tumour arising from melanocytes, represents the most aggressive form of skin cancer. While it accounts for a smaller percentage of skin cancer cases compared to basal cell and squamous cell carcinomas, it is responsible for the vast majority of skin cancer-related deaths. Its incidence has been rising globally over the past decades. In Hong Kong, data from the Hong Kong Cancer Registry indicates a steady increase in melanoma cases, with an age-standardised incidence rate that underscores its growing public health significance. The prognosis of melanoma is critically dependent on the stage at diagnosis. Early-stage, thin melanomas (e.g., Breslow thickness
Despite its visual accessibility on the skin, the clinical diagnosis of early melanoma remains fraught with challenges. Naked-eye examination, even with the aid of a standard dermatology magnifying lens, has significant limitations in sensitivity and specificity. Many early melanomas are small, flat, and lack the classic "ABCD" features (Asymmetry, Border irregularity, Colour variegation, Diameter >6mm) that are taught for public awareness. They can closely resemble benign lesions such as atypical nevi, seborrheic keratoses, or vascular lesions. Furthermore, the human eye cannot reliably discern subsurface structures and pigment patterns critical for differentiating benign from malignant. This diagnostic uncertainty leads to a high number of unnecessary excisions of benign lesions and, conversely, the potential for missing subtle, early melanomas. It is within this diagnostic gap that dermoscopy has emerged as a transformative, non-invasive imaging technique, bridging the divide between clinical inspection and histopathology.
II. Dermoscopy as a Tool for Melanoma Diagnosis
Dermoscopy, also known as dermatoscopy or epiluminescence microscopy, is a non-invasive diagnostic technique that allows for the in vivo, magnified observation of skin lesions. By using a handheld device that combines magnification (typically 10x) with either polarized light (which eliminates surface reflection) or immersion fluid with a non-polarized light source, it renders the stratum corneum translucent. This enables the clinician to visualise morphological features in the epidermis, the dermo-epidermal junction, and the superficial dermis that are otherwise invisible to the naked eye. The transition from a standard dermatology magnifying lens to a dedicated dermoscope is akin to moving from a simple magnifying glass to a microscope for skin examination.
Numerous meta-analyses and clinical studies have conclusively demonstrated that dermoscopy significantly improves the diagnostic accuracy for melanoma compared to naked-eye examination alone. It increases the sensitivity (the ability to correctly identify melanoma) by approximately 10-30%, reducing the number of missed melanomas. Perhaps more importantly for clinical practice, it enhances specificity (the ability to correctly identify benign lesions) by 5-20%, leading to a substantial decrease in the number of unnecessary biopsies. This dual benefit—catching more cancers while removing fewer benign lesions—is the cornerstone of its value. A key structured approach within dermoscopy is the ABCD rule, later expanded to ABCDE. In dermoscopy, these letters take on specific, microscopic meanings: A for Asymmetry in structure and colour, B for an irregular, sharp Border of the pigment network, C for multiple Colours (white, red, blue, black, gray), and D for the presence of Differential structures (dots, globules, streaks). The added E stands for Evolution, a critical clinical history component. This systematic framework provides a reproducible method for analysing pigmented lesions and quantifying the risk of malignancy.
III. Dermoscopic Features of Early Melanoma
Early melanomas, particularly those in the radial growth phase, often present with subtle dermoscopic clues that require trained recognition. Unlike advanced lesions with obvious multicomponent patterns, early signs can be focal and discrete. A common early sign is the presence of atypical, brown-black dots/globules that are irregular in size, shape, and distribution, often located at the periphery of the lesion. Regression structures, such as white scar-like areas (fibrosis) and blue-gray peppering (fine granules representing melanophages), are highly suggestive of melanoma, even in small lesions. These features indicate an active host immune response against the tumour.
Variations in the pigment network are a central diagnostic pillar. The pigment network appears as a grid of brown lines over a lighter background, corresponding to rete ridges. In benign nevi, the network is typically regular, homogeneous, and fades gradually at the periphery. In early melanoma, the network becomes atypical: it may show abrupt termination at the lesion's edge, have lines that are irregular in thickness and colour, or exhibit focal areas of thickening (broadened network) or disruption. A hallmark feature is the so-called "negative network"—a pattern of light, serpigineous lines on a dark background, which is highly specific for melanoma.
Vascular patterns, often overlooked in pigmented lesions, provide crucial information, especially in hypomelanotic or amelanotic melanomas. Under dermoscopy, atypical vascular patterns include linear-irregular vessels (fine, serpentine vessels that do not follow a regular pattern), dotted vessels (tiny red dots), and milky-red globules/areas (hazy, pinkish-white structures). The presence of polymorphous vessels (more than one type of atypical vessel) within a lesion is a strong indicator of malignancy. Recognising these vascular features requires practice, as they can be subtle and are best visualised with non-polarised, contact dermoscopy or with specific polarising filters.
IV. Case Studies of Early Melanoma Detection with Dermoscopy
To illustrate the practical application, consider a hypothetical case from a Hong Kong dermatology clinic. A 45-year-old patient presents with a 4mm, slightly asymmetrical, light brown macule on the upper back, noted during a routine check. Naked-eye examination with a standard dermatology magnifying lens might dismiss it as a simple lentigo or a flat nevus. However, dermoscopic evaluation reveals a focal area of atypical, thickened brown network with abrupt edge interruption on one segment. Scattered irregular brown dots are present at the periphery, and a tiny area of blue-white veil is noted. These features, while not dramatic, collectively raise a high index of suspicion for an early melanoma in situ. Following the "3-point checklist" algorithm (asymmetry, atypical network, blue-white structures), this lesion scores 3 points, warranting excision. Histopathology confirms the diagnosis, allowing for curative treatment with a narrow margin.
Another case involves a 3mm pinkish papule on the cheek of a 60-year-old. Clinically, it could be mistaken for a basal cell carcinoma or a benign vascular lesion. Dermoscopy, however, shows a central ulceration surrounded by linear-irregular vessels and milky-red areas, with no signs of arborising vessels (typical of BCC) or lacunae (typical of haemangioma). This vascular pattern is classic for an amelanotic melanoma. The use of diagnostic algorithms, such as the 7-point checklist, the Menzies method, or the more recent and evidence-based iDScore, guides the clinician through a structured analysis of dermoscopic criteria, translating visual patterns into a quantifiable risk score. This systematic approach reduces diagnostic reliance on intuition alone and supports confident decision-making for biopsy or monitoring.
V. Limitations and Pitfalls of Dermoscopy
The efficacy of dermoscopy is inextricably linked to the expertise and training of the user. It is a skill that requires dedicated learning and continuous practice. Studies show a significant learning curve; diagnostic accuracy improves markedly after structured training courses and the review of several hundred lesions. Without proper training, there is a risk of misinterpreting features, leading to both false positives and false negatives. In Hong Kong, while dermoscopy is increasingly adopted in dermatology and family medicine, ensuring adequate training for all practitioners remains a challenge. Mastery involves not only recognising patterns but also understanding their histopathological correlates.
A major pitfall is the existence of numerous melanoma mimics—benign lesions that can display alarming dermoscopic features. These include recurrent nevi, traumatised or inflamed nevi, pigmented Spitz nevi, and certain seborrheic keratoses or dermatofibromas. For instance, a pigmented Spitz nevus may exhibit a striking starburst pattern with peripheral streaks, mimicking a melanoma. A regressing lichen planus-like keratosis can show blue-gray peppering identical to that seen in melanoma regression. Distinguishing these mimics requires a deep knowledge of the full spectrum of dermoscopic appearances across all skin lesions.
It is crucial to remember that dermoscopy is a diagnostic aid, not a replacement for histopathology. Its role is to triage lesions and increase the pre-test probability for biopsy. The definitive diagnosis of melanoma still requires a biopsy. Dermoscopy can guide the biopsy technique, suggesting the most atypical area to sample in a large lesion. Furthermore, digital dermoscopic monitoring (sequential imaging over time) is a powerful adjunct for managing clinically and dermoscopically equivocal lesions, where subtle change over months is the key diagnostic criterion. In conclusion, when wielded by a trained clinician, dermoscopy transforms the dermatology magnifying lens into a powerful window into the skin's microanatomy, playing an indispensable role in the early, life-saving detection of melanoma.
By:Silverdew